Brainstorm Cell Therapeutics Inc. Common Stock is a biotechnology company that is focused on developing innovative stem cell-based therapies for neurodegenerative diseases such as Parkinson’s and ALS. With a strong scientific team and promising clinical trials, the company is positioned to make a significant impact in the field of regenerative medicine.
